fda compounding semaglutide warning letters news Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots FDA Warns on Certain Forms

You can schedule a consultation directly with an obesity specialist or weight management provider

With seven additional Phase 3 readouts expected in 2026, the company believes retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis

June 1, 2025

The team at Mind Matters Psychiatry & Weight Loss in Longwood, Florida, specializes in evidence-based medical weight-loss programs, including GLP-1 therapies such as semaglutide and tirzepatide.

What is my long-term plan if I achieve my weight loss goal - will I continue medication indefinitely, or transition to maintenance strategies

Other eligible GLP-1 drugs available through the Bridge program are Wegovy (pens and tablets) and Foundayo